Congratulations to Thushara Vajera Perera on his appointment as the CEO of SLINTEC. With his extensive expertise in translating fundamental research into product development and successful commercialization, SLINTEC is set to enter a new era of innovation. Thushara’s previous roles as a senior scientist at Celera Genomics, Amgen, and Pfizer, coupled with his studies and training at Harvard University, have equipped him with the necessary skills and knowledge to drive SLINTEC’s growth. We warmly welcome Thushara Vajera Perera aboard and look forward to the exciting journey ahead!

#SLINTEC #innovation #development #research #ceo #growth